CRGA - artsen

Medicine & Life Sciences

1. Intracytoplasmic Sperm Injections 100%
2. Oocytes 92%
3. Embryonic Structures 86%
4. Ovulation Induction 72%
5. Embryo Transfer 72%
6. Preimplantation Diagnosis 60%
7. Live Birth 58%
8. Fertilization in Vitro 51%
9. Spermatozoa 50%
10. Birth Rate 48%
11. Pregnancy Rate 46%
12. Gonadotropin-Releasing Hormone 45%
13. Pregnancy 39%
14. Blastocyst 35%
15. Progesterone 35%
16. Infertility 30%
17. Cryopreservation 25%
18. Oocyte Donation 24%
19. Assisted Reproductive Techniques 23%
20. Reproduction 22%
21. Blastomeres 22%
22. Fertility 21%
23. Single Embryo Transfer 20%
24. Fertility Preservation 20%
25. Fertilization 19%
26. Luteal Phase 19%
27. Pregnancy Outcome 19%
28. Prostaglandins D 18%
29. Oocyte Retrieval 18%
30. In Vitro Oocyte Maturation Techniques 17%
31. Follicular Phase 17%
32. Randomized Controlled Trials 16%
33. Vitrification 16%
34. Germ Cells 16%
35. Biopsy 16%
36. Chorionic Gonadotropin 16%
37. Insemination 15%
38. Genetic Testing 15%
39. Dydrogesterone 15%
40. Aneuploidy 15%
41. Polycystic Ovary Syndrome 15%
42. Hormone Antagonists 14%
43. In Vitro Techniques 14%
44. Gonadotropins 14%
45. Menotropins 13%
46. Estradiol 13%
47. Child 13%
48. Antral 13%
49. Cumulus Cells 13%
50. follicle stimulating hormone, human, with HCG C-terminal peptide 12%
51. Klinefelter Syndrome 12%
52. Male Infertility 12%
53. Serum 12%
54. Cohort Studies 12%
55. Polymerase Chain Reaction 12%
56. Therapeutics 12%
57. Corpus Luteum 12%
58. Semen 11%
59. Endometrium 11%
60. Embryo Implantation 11%
61. Genes 11%
62. Embryonic Development 11%
63. Azoospermia 10%
64. Ovarian Hyperstimulation Syndrome 10%
65. Freezing 10%
66. Mutation 10%
67. Hormones 9%
68. Tissue Donors 9%
69. Ovulation 9%
70. Ovarian Reserve 9%
71. Reproductive Medicine 8%
72. Ovary 8%
73. Obstetrics 8%
74. Belgium 8%
75. Endometriosis 8%
76. Spontaneous Abortion 8%
77. Zygote 8%
78. Retrospective Studies 7%
79. Human Development 7%
80. Fluorescence In Situ Hybridization 7%
81. Neoplasms 7%
82. Multiple Pregnancy 7%
83. Safety 7%
84. First Pregnancy Trimester 7%
85. Systematic Reviews 7%
86. Human Embryonic Stem Cells 6%
87. Myotonic Dystrophy 6%
88. Menstrual Cycle 6%
89. Luteinizing Hormone 6%
90. Multicenter Studies 6%
91. Gene Expression 6%
92. Maternal Age 6%
93. Follicle Stimulating Hormone 6%
94. Prospective Studies 6%
95. SARS Virus 6%
96. Clomiphene 6%
97. Metaphase 6%
98. Embryo Disposition 6%
99. Regression Analysis 5%
100. Testosterone 5%